Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,113,915
+$626,441 QoQ
Shares Held
8,282
+6.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#516
of 1,735 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 60%
Shared 40%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dempze Nancy E holds $4,425,685 across 2 Biotechnology names. VRTX ranks #1 (93.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,282 | $4,113,915 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
500 | $311,770 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,113,915 | 8,282 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,487,474 | 7,810 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,199,812 | 7,058 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,840,169 | 7,252 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,196,534 | 7,180 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,424,279 | 7,063 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,447,206 | 6,077 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,264,472 | 4,869 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,210,701 | 2,583 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $294,696 | 705 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||